Results 111 to 120 of about 304,923 (295)

Complementary Therapies in Cerebral Palsy

, 2021
Pınar Akpınar
openalex   +2 more sources

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

Complementary and Alternative Therapies for Inflammatory Diseases 2018 [PDF]

, 2018
Ying‐Ju Lin, Yuan Xu, Junji Xu
openalex   +1 more source

Complementary Treatment for Women with Breast Cancer: A Psychomotor Therapy Approach

, 2022
Guida Veiga, Graça Santos
openalex   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Yoga as a complementary therapy in neuropathic pain: A systematic review and meta-analysis of randomized controlled trials. [PDF]

J Family Med Prim Care, 2023
Bhardwaj P, Ahuja N, Parchani A, Singh S, Sethi D, Pathania M.   +5 more
europepmc   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Editorial: Complementary therapies for neurological disorders: from bench to clinical practices

Frontiers in Neurology, 2023
Yang Ye, Shuren Li, Lingyong Xiao, Jingling Chang   +3 more
doaj   +1 more source

Quercetin as a possible complementary therapy in multiple sclerosis: Anti-oxidative, anti-inflammatory and remyelination potential properties. [PDF]

Heliyon, 2023
Javanbakht P, Yazdi FR, Taghizadeh F, Khadivi F, Hamidabadi HG, Kashani IR, Zarini D, Mojaverrostami S.   +7 more
europepmc   +1 more source

Testing the efficacy of yoga as a complementary therapy for smoking cessation: Design and methods of the BreathEasy trial

, 2014
Beth C. Bock, Rochelle K. Rosen, Joseph L. Fava, Ronnesia B. Gaskins, Ernestine Jennings, Herpreet Thind, James Carmody, Shira Dunsiger, Naama Gidron, Bruce M. Becker, Bess H. Marcus   +10 more
openalex   +2 more sources